A randomised, double-blind, placebo-controlled, dosefinding study evaluating efficacy, safety and tolerability of different oral doses of BI1819479 over at least 24 weeks in patients with idiopathic pulmonary fibrosis (IPF)

Project: Research

Project Details

StatusActive
Effective start/end date25/09/24 → 25/09/26

Keywords

  • clinical trial
  • Pulmonary Fibrosis
  • respiratory diseases

Clinical Trial Phase

  • Phase II